A UK analysis of the cost-effectiveness of Humalog Mix75/25 and Mix50/50 versus long-acting basal insulin.
about
Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literatureHow Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review.Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.
P2860
A UK analysis of the cost-effectiveness of Humalog Mix75/25 and Mix50/50 versus long-acting basal insulin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A UK analysis of the cost-effe ...... sus long-acting basal insulin.
@en
A UK analysis of the cost-effe ...... sus long-acting basal insulin.
@nl
type
label
A UK analysis of the cost-effe ...... sus long-acting basal insulin.
@en
A UK analysis of the cost-effe ...... sus long-acting basal insulin.
@nl
prefLabel
A UK analysis of the cost-effe ...... sus long-acting basal insulin.
@en
A UK analysis of the cost-effe ...... sus long-acting basal insulin.
@nl
P2093
P2860
P1433
P1476
A UK analysis of the cost-effe ...... sus long-acting basal insulin.
@en
P2093
Bradley H Curtis
Jayne Smith-Palmer
William J Valentine
P2860
P2888
P304
P356
10.1007/S12325-012-0065-1
P407
P577
2012-11-22T00:00:00Z